Justine Telliez
Stock Analyst at Kepler Capital
(4.93)
# 181
Out of 4,649 analysts
354
Total ratings
55.9%
Success rate
61.6%
Average return
Main Sectors:
Stocks Rated by Justine Telliez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | €5.50 | €2.37 | +132.46% | 26 | May 4, 2026 | |
| EPA: GBT Guerbet SA | Maintained: Hold | €13.80 | €8.05 | +71.43% | 24 | Apr 24, 2026 | |
| BIT: PHIL Philogen S.p.A. | Maintained: Buy | €34.00 | €23.30 | +45.92% | 1 | Apr 24, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 167.00 | CHF 173.00 | -3.47% | 12 | Apr 23, 2026 | |
| EPA: ADOC Adocia SA | Maintained: Buy | €12.00 | €4.15 | +189.44% | 26 | Apr 22, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €132.00 | €156.00 | -15.38% | 35 | Apr 22, 2026 | |
| EPA: ABVX ABIVAX Société Anonyme | Maintained: Buy | €130.00 | €102.70 | +26.58% | 33 | Apr 13, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Maintained: Hold | €0.40 | €0.10 | +310.26% | 31 | Apr 8, 2026 | |
| EPA: GNFT Genfit S.A. | Maintained: Buy | €15.00 | €13.02 | +15.21% | 42 | Apr 7, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | CHF 5.92 | -23.92% | 36 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €7.70 → €5.60 | €3.00 | +86.67% | 63 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.10 | €1.86 | n/a | 24 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.30 | €2.89 | n/a | 1 | Dec 1, 2023 |
DBV Technologies S.A.
May 4, 2026
Maintained: Buy
Price Target: €5.50
Current: €2.37
Upside: +132.46%
Guerbet SA
Apr 24, 2026
Maintained: Hold
Price Target: €13.80
Current: €8.05
Upside: +71.43%
Philogen S.p.A.
Apr 24, 2026
Maintained: Buy
Price Target: €34.00
Current: €23.30
Upside: +45.92%
Galderma Group AG
Apr 23, 2026
Maintained: Buy
Price Target: CHF 167.00
Current: CHF 173.00
Upside: -3.47%
Adocia SA
Apr 22, 2026
Maintained: Buy
Price Target: €12.00
Current: €4.15
Upside: +189.44%
Ipsen S.A.
Apr 22, 2026
Maintained: Hold
Price Target: €132.00
Current: €156.00
Upside: -15.38%
ABIVAX Société Anonyme
Apr 13, 2026
Maintained: Buy
Price Target: €130.00
Current: €102.70
Upside: +26.58%
GenSight Biologics S.A.
Apr 8, 2026
Maintained: Hold
Price Target: €0.40
Current: €0.10
Upside: +310.26%
Genfit S.A.
Apr 7, 2026
Maintained: Buy
Price Target: €15.00
Current: €13.02
Upside: +15.21%
Idorsia Ltd
Mar 30, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: CHF 5.92
Upside: -23.92%
Mar 26, 2026
Maintained: Buy
Price Target: €7.70 → €5.60
Current: €3.00
Upside: +86.67%
May 23, 2025
Maintained: Hold
Price Target: €3.10
Current: €1.86
Upside: n/a
Dec 1, 2023
Maintained: Buy
Price Target: €16.30
Current: €2.89
Upside: n/a